摘要
简介:痴呆症患者死于中风的风险可能更高。我们旨在描述瑞典死于缺血性中风(IS)的痴呆患者的特征。方法:对在瑞典痴呆登记处登记的患者前瞻性收集的资料进行回顾性纵向分析。关于死亡原因、毒品和同居的数据是从瑞典全国卫生登记册获得的。如果死亡证明中包含中风作为死亡原因,并且病人在死亡前一年在瑞典中风登记中心登记了中风,那么死亡就是中风造成的。比较了老年痴呆症诊断时的人口学数据,比较了因IS死亡的患者与未登记的IS患者与因其他原因死亡的患者之间的差异。结果:截至2014年底,在初级保健或专科诊所诊断的49823例痴呆患者中,14170例(28.4%)死亡。其中有1180人(8.3%)在死亡证明中登记,其中459人(38.9%)在议会中风登记。在死于血管性痴呆的患者中,最常见的类型是血管性痴呆,而死于其他原因的人往往被诊断为老年痴呆症(AD)。死于脑卒中的患者MMSE评分高于其他组。死于IS的病人服用了更多的心血管药物。两组在使用抗精神病药、抗抑郁药、乙酰胆碱酯酶抑制剂、美金刚、抗焦虑药或催眠药方面没有差异。结论:死亡证明中显示的死于IS的人数较多,但死亡前一年未登记为中风患者。这引起了对死亡证明中风诊断的准确性的关注,特别是对于医院外发生的死亡事件。
关键词: 瑞典痴呆登记处,瑞典中风登记处,瑞典中风登记处,Rikske,痴呆,缺血性中风,死亡证明。
Current Alzheimer Research
Title:Stroke as a Cause of Death in Death Certificates of Patients with Dementia: A Cohort Study from the Swedish Dementia Registry
Volume: 15 Issue: 14
关键词: 瑞典痴呆登记处,瑞典中风登记处,瑞典中风登记处,Rikske,痴呆,缺血性中风,死亡证明。
摘要: Introduction: Patients with dementia may be at a higher risk for death from stroke. We aimed to describe characteristics of dementia patients that died from ischemic stroke (IS) in Sweden.
Methods: A retrospective longitudinal analysis of prospectively collected data of patients registered into the Swedish Dementia Registry was conducted. Data on causes of death, drugs and comorbidities were acquired from the Swedish nationwide health registers. Deaths were attributed to stroke if the death certificate contained stroke as a cause of death and the patient had a stroke registered in Riksstroke, the Swedish Stroke Register, in the year preceding death. Demographic data at the time of dementia diagnosis was compared between patients dying from IS and registered in Riksstroke, patients dying from IS without being registered in Riksstroke and those dying from other causes.
Results: Out of 49823 patients diagnosed with dementia between 2007 and 2014 in primary care or specialist clinics, 14170 (28.4%) had died by the end of 2014. Of these 1180 (8.3%) had IS in their death certificate, of which 459 (38.9%) had been registered in Riksstroke. In patients who died of IS the most common type of dementia was vascular dementia while those died from other causes were most often diagnosed with Alzheimer’s dementia (AD). Patients who died from IS and were registered in Riksstroke had higher MMSE score compared to other groups. Patients who died from IS took more cardiovascular medications. There were no differences in the use of antipsychotics, antidepressants, acetylcholinesterase inhibitors, memantine, anxiolytics, or hypnotics between the groups.
Conclusions: There was a relatively high number of patients who died from IS as shown in their death certificate but had not been registered in Riksstroke in the year before death. This creates concerns on the accuracy of death certificate stroke diagnoses, particularly for deaths taking place outside hospitals.
Export Options
About this article
Cite this article as:
Stroke as a Cause of Death in Death Certificates of Patients with Dementia: A Cohort Study from the Swedish Dementia Registry, Current Alzheimer Research 2018; 15 (14) . https://dx.doi.org/10.2174/1567205015666181002134155
DOI https://dx.doi.org/10.2174/1567205015666181002134155 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Test Your Memory (TYM) Test Outperforms the MMSE in the Detection of MCI and Dementia
Current Alzheimer Research Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations
Current Cardiology Reviews Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Cerebrovascular Profile Assessment in Parkinson's Disease Patients
CNS & Neurological Disorders - Drug Targets Proteases Essential for Human Influenza Virus Entry into Cells and Their Inhibitors as Potential Therapeutic Agents
Current Pharmaceutical Design Oxysterol Derivatives of Cholesterol in Neurodegenerative Disorders
Current Medicinal Chemistry Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People
Current Alzheimer Research Pharmacogenomics and the Treatment of Sporadic Alzheimers Disease:A Decade of Progress
Current Pharmacogenomics and Personalized Medicine Cerebrospinal-fluid Alzheimer’s Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson’s Disease Patients
CNS & Neurological Disorders - Drug Targets Blood Pressure and the Risk of Dementia: A Dose-Response Meta-Analysis of Prospective Studies
Current Neurovascular Research Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Current Alzheimer Research PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?
Current Pharmaceutical Design Modulatory Effect of Sinapic Acid in Toluene Induced Dementia of Leukoencephalopathy Type in Wistar Rats: a Biochemical Study
The Natural Products Journal Quality Control Optimization Solutions for Determination of Rutin in Supplements Containing Ginkgo Biloba Extract
Current Pharmaceutical Analysis Diabetes Exacerbates Nanoparticles Induced Brain Pathology
CNS & Neurological Disorders - Drug Targets The Influence of Sex Hormones on Pulmonary Vascular Reactivity: Possible Vasodilator Therapies for the Treatment of Pulmonary Hypertension
Current Vascular Pharmacology Angiotensin-Receptor Blockers and the Risk of Alzheimer´s Disease: A Meta-analysis
Current Reviews in Clinical and Experimental Pharmacology Missing Uniform Costs Classification for Alzheimer’s Disease Treatment and Care
Current Alzheimer Research Protein Aggregation in Neurodegenerative Diseases: Insights from Computational Analyses
Current Bioinformatics A Model on the Induction of Adverse Vascular Long-Term Effects of NSAIDs
Medicinal Chemistry